A state-run research institute in China has applied for a patent on the use of Gilead’s experimental antiviral drug remdesivir, which has been suggested as a potential treatment for the cor
The Netherlands’ biotech sector has already seen an upswing following the relocation of the European Medicines Agency (EMA) to Amsterdam following Brexit, according to an influential figure
GlaxoSmithKline has joined with the not-for-profit organisation the Coalition for Epidemic Preparedness Innovations (CEPI) to supply a booster for a potential Wuhan coronavirus vaccine.
Alector has launched an $208 million stock market offering as it ramps up clinical trials with AbbVie into a drug that aims to tackle Alzheimer’s by modifying the brain’s immune system.
